A detailed history of William B. Walkup & Associates, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, William B. Walkup & Associates, Inc. holds 11,108 shares of ABT stock, worth $1.5 Million. This represents 0.8% of its overall portfolio holdings.

Number of Shares
11,108
Previous 11,641 4.58%
Holding current value
$1.5 Million
Previous $1.33 Billion 5.33%
% of portfolio
0.8%
Previous 0.82%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

SELL
$111.93 - $119.39 $59,658 - $63,634
-533 Reduced 4.58%
11,108 $1.26 Billion
Q3 2024

Nov 14, 2024

BUY
$100.07 - $118.13 $2,201 - $2,598
22 Added 0.19%
11,641 $1.33 Billion
Q2 2024

Aug 15, 2024

BUY
$100.73 - $112.44 $1.17 Million - $1.31 Million
11,619 New
11,619 $1.21 Billion

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $236B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track William B. Walkup & Associates, Inc. Portfolio

Follow William B. Walkup & Associates, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of William B. Walkup & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on William B. Walkup & Associates, Inc. with notifications on news.